Latest Capital Strategy News

Jayride Group continues its pivot to a SaaS mobility platform across Australasia and Southeast Asia, managing tight cash flow and planning a capital raise to sustain operations and support ASX reinstatement.

Scentre Group has successfully tendered 89% of its US$1.312 billion 2030 subordinated notes and plans to redeem the remainder, boosting liquidity to A$3.2 billion while maintaining 4% growth targets for 2026.

Regis Healthcare expects FY26 underlying EBITDA of approximately $135 million, buoyed by near-record occupancy and a disciplined capital strategy amid evolving government reforms.

Microba Life Sciences reported a 99% year-on-year surge in core testing revenue for Q3 FY26, propelled by strong test volume growth and new clinic contracts in Australia and the UK. The company is advancing a major product release and negotiating a significant corporate transaction to bolster its financial position.

Estrella Resources has initiated Timor-Leste’s inaugural hard rock mineral extraction at its Ira Miri manganese project, advancing towards full-scale mining and simultaneously progressing a major limestone resource at Werumata.

Mayne Pharma’s third quarter results show modest revenue growth but a sharp improvement in cash flow and earnings, powered by the strong launch of DistributeRx and robust Women’s Health sales.

Fat Prophets Global Contrarian Fund (ASX: FPC) is raising up to $8.45 million through a pro-rata rights issue priced at a premium, offering one option per new share. The issue is partly underwritten and sees directors committing to full participation.

Metro Mining has secured shareholder approval for a 1-for-20 share consolidation, cutting its shares on issue from over 6.1 billion to roughly 307 million. The move aims to streamline the capital structure and attract broader investor interest.

Cooper Metals has swapped its Oorindi Project for the Pyramid Gold Project in North Queensland, a high-grade gold asset in the prolific Drummond Basin. The company plans immediate exploration and a $979,500 capital raise to fund drilling and technical expansion.

Peninsula Energy (ASX: PEN) has voluntarily suspended trading of its shares pending a Supreme Court decision on the validity of share sales made earlier this year. The court hearing, set for 22 April, will determine if required disclosures were properly made for sales between February and April 2026.

MA Credit Income Trust has approved an on-market buy-back of its units, adding a flexible tool to its capital management arsenal amid evolving market conditions.

Ramsay Health Care has announced a fully franked distribution of AUD 3.3608 per security on its perpetual preference shares, subject to board approval by late August. The payment reflects a total annualised rate of 6.7%, linked to the 180-day BBSW plus a margin.